Fuse Biotherapeutics Sweden AB

ABIn liquidation

Org 5594237389StockholmEconomic activity was not specified by tax authority · NACE 0000Est. 20230 employees

Overview Financials People & ownership Related companies

Fuse Biotherapeutics Sweden AB is a Swedish AB based in Stockholm, operating in the Huvudnäring okänd sector. Incorporated in 2023, the company has 0 employees and reported revenue of SEK 0 in its latest annual filing.

Revenue 2024

SEK 0

EBITDA margin

—

+25% vs 2023

Equity ratio

100.0%

Financial strength

Net profit 2024

SEK -9K

-800% vs 2023

EBITDA — year on year

SEK millions

Key figures

Annual report 2024

Revenue	SEK 0	—
EBITDA	SEK -9K	+25%
Net profit	SEK -9K	-800%
Total assets	SEK 15K	-37%
Equity	SEK 15K	-37%
Employees	0	—

Contact

Address

Stockholm

Risika for professionals

Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.

Visit risika.com

Frequently asked questions

What is the Org number of Fuse Biotherapeutics Sweden AB?

Fuse Biotherapeutics Sweden AB is registered with Bolagsverket / SCB under Org 5594237389.

Who is the CEO of Fuse Biotherapeutics Sweden AB?

Jan Anders Fredrik Lovén is Liquidator of Fuse Biotherapeutics Sweden AB, in role since 2025.

Who is the chairman of Fuse Biotherapeutics Sweden AB?

Jan Totte Dahlin chairs the board of Fuse Biotherapeutics Sweden AB, in role since 2023.

Where is Fuse Biotherapeutics Sweden AB headquartered?

Fuse Biotherapeutics Sweden AB's registered address is Stockholm.

Fuse Biotherapeutics Sweden AB

EBITDA — year on year

Key figures

Company information

Contact

Frequently asked questions

More on Fuse Biotherapeutics Sweden AB

EBITDA — year on year

Key figures

Company information

Contact

Frequently asked questions

More on Fuse Biotherapeutics Sweden AB